Dexmedetomidine in Patients With Sepsis Requiring Mechanical Ventilation

20:00 EDT 31 Jul 2017 | JAMA

To the Editor The trial by Dr Kawazoe and colleagues found no significant differences in ventilator-free days and mortality rates after 28 days among patients with sepsis receiving mechanical ventilation who did or did not receive dexmedetomidine, in contrast to previous randomized clinical trials and systematic reviews. The beneficial effects of dexmedetomidine in these studies suggest additional positive effects of α2-antagonists in sepsis due to its sympatholytic effects, limiting adrenergic stress as has been described for β-blocker treatment. Consequently, other explanations for the findings of Kawazoe and colleagues should be sought. There are several limitations of the present study that should be discussed.

Original Article: Dexmedetomidine in Patients With Sepsis Requiring Mechanical Ventilation


More From BioPortfolio on "Dexmedetomidine in Patients With Sepsis Requiring Mechanical Ventilation"

Quick Search

Relevant Topics

Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...